Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study

被引:8
|
作者
Wang, Yuanying [1 ]
Guo, Ziyun [1 ]
Ma, Ruimin [1 ]
Wang, Jingwei [1 ]
Wu, Na [1 ,2 ]
Fan, Yali [1 ]
Ye, Qiao [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Clin Ctr Interstitial Lung Dis, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Occupat Med & Toxicol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
progressive fibrosing interstitial lung disease; prognosis; lung function test; blood count values; anti-fibrotic treatment; IDIOPATHIC PULMONARY-FIBROSIS; PIRFENIDONE; DIAGNOSIS;
D O I
10.3389/fphar.2022.924754
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD.Methods: This retrospective cohort study included patients with fibrosing ILD who were investigated between 1 January 2015 and 30 April 2021. We recorded clinical features and outcomes to identify the possible risk factors for fibrosing progression as well as mortality.Results: Of the 579 patients with fibrosing ILD, 227 (39.21%) met the criteria for progression. Clubbing of fingers [odds ratio (OR) 1.52, 95% confidence interval (CI) 1.03 to 2.24, p = 0.035] and a high-resolution computed tomography (HRCT)-documented usual interstitial pneumonia (UIP)-like fibrotic pattern (OR 1.95, 95% CI 1.33 to 2.86, p = 0.001) were risk factors for fibrosis progression. The mortality was worse in patients with PF with hypoxemia [hazard ratio (HR) 2.08, 95% CI 1.31 to 3.32, p = 0.002], in those with baseline diffusion capacity of the lung for carbon monoxide (DLCO) % predicted <50% (HR 2.25, 95% CI 1.45 to 3.50, p < 0.001), or in those with UIP-like fibrotic pattern (HR 1.68, 95% CI 1.04 to 2.71, p < 0.001).Conclusion: Clubbing of fingers and an HRCT-documented UIP-like fibrotic pattern were more likely to be associated with progressive fibrosing with varied prevalence based on the specific diagnosis. Among patients with progressive fibrosing, those with hypoxemia, lower baseline DLCO% predicted, or UIP-like fibrotic pattern showed poor mortality.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
    Kawamura, Kodai
    Ichikado, Kazuya
    Anan, Keisuke
    Yasuda, Yuko
    Sekido, Yuko
    Suga, Moritaka
    Ichiyasu, Hidenori
    Sakagami, Takuro
    CHRONIC RESPIRATORY DISEASE, 2020, 17
  • [2] Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study
    Ji Su-yun
    Zeng Fan-qin
    Guo Qing
    Tan Guo-zhen
    Tang Hong-feng
    Luo Yi-jin
    Tang Zeng-qi
    Han Yan-fang
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 517 - 522
  • [3] Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
    Denis, Anna
    Henket, Monique
    Ernst, Marie
    Maes, Nathalie
    Thys, Marie
    Regnier, Celine
    Malaise, Olivier
    Frix, Anne-Noelle
    Gester, Fanny
    Desir, Colin
    Meunier, Paul
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    FRONTIERS IN MEDICINE, 2022, 9
  • [4] Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study
    Hyun, Dong-gon
    Han, Soo Jin
    Ji, Wonjun
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Ho Cheol
    THORACIC CANCER, 2023, 14 (33) : 3323 - 3330
  • [5] Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
    Nasser, Mouhamad
    Larrieu, Sophie
    Si-Mohamed, Salim
    Ahmad, Kais
    Boussel, Loic
    Brevet, Marie
    Chalabreysse, Lara
    Fabre, Celine
    Marque, Sebastien
    Revel, Didier
    Thivolet-Bejui, Francoise
    Traclet, Julie
    Zeghmar, Sabrina
    Maucort-Boulch, Delphine
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [6] Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
    Han, Soo Jin
    Kim, Hyeon Hwa
    Hyun, Dong-gon
    Ji, Wonjun
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Ho Cheol
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [7] Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
    Soo Jin Han
    Hyeon Hwa Kim
    Dong-gon Hyun
    Wonjun Ji
    Chang-Min Choi
    Jae Cheol Lee
    Ho Cheol Kim
    BMC Pulmonary Medicine, 24
  • [8] Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
    Jensen, Mads Lynge
    Lokke, Anders
    Hilberg, Ole
    Hyldgaard, Charlotte
    Bendstrup, Elisabeth
    Tran, Dan
    EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2019, 6 (01):
  • [9] Cancer of the Lung-6 as a potential predictive Biomarker in Patients with fibrosing interstitial Lung Disease
    Lederer, C.
    Mayer, K.
    Somogyi, V
    Kriegsmann, K.
    Kriegsmann, M.
    Buschulte, K.
    Polke, M.
    Findeisen, P.
    Herth, F.
    Kreuter, M.
    PNEUMOLOGIE, 2024, 78 : S77 - S77
  • [10] Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease
    Watase, Mayuko
    Mochimaru, Takao
    Kawase, Honomi
    Shinohara, Hiroyuki
    Sagawa, Shinobu
    Ikeda, Toshiki
    Yagi, Shota
    Yamamura, Hiroyuki
    Matsuyama, Emiko
    Kaji, Masanori
    Kurihara, Momoko
    Sato, Midori
    Horiuchi, Kohei
    Watanabe, Risa
    Nukaga, Shigenari
    Irisa, Kaoru
    Satomi, Ryosuke
    Oyamada, Yoshitaka
    PLOS ONE, 2023, 18 (03):